Similar Posts
Okta Remains A Buy As Steady Recurring Revenue And AI Progress Impress
Okta Remains A Buy As Steady Recurring Revenue And AI Progress Impress Source link
AI Scenarios: From Doomsday Destruction to Do-Nothing Bots!
When Chat GPT made its debut on November 30, 2022, it unleashed the hype of AI, and in the three years since, AI has taken on an outsized role not just in markets, but also in our lives. For much of the time, the AI story has been told by its advocates and…
Algo- & AutoXpert
Algo- & AutoXpert Source link
Ajanta Pharma Shares Gain 5% After Semaglutide Deal With Biocon
December 24, 2025December 24, 2025 Shares of Ajanta Pharma Ltd. surged 5% to touch a day’s high of Rs 2,824 on 24th December. This occurred after the company said it had inked an in-licensing agreement with Biocon Ltd. for semaglutide, a GLP-1 receptor agonist. Under…
Japan’s Nikkei hits record high as chip-related shares jump
Japan’s Nikkei hits record high as chip-related shares jump Source link
Aether Scalper: 87% Win Rate AI-Driven Strategy for EURUSD
Title : Aether Scalper -The Pinnacle of Proprietary EURUSD Signal Intelligence ■ BRIEF DESCRIPTION Aether AI Elite is not just another trading bot; it is a sophisticated, non-standard algorithmic powerhouse engineered exclusively for the EURUSD. This system is built upon a Proprietary Signal Synthesis Engine that has been rigorously validated to ensure professional-grade performance and astonishing…
